Skip to main content

Table 2 Clinical characteristics and outcomes associated with TTP in 52 children with P. aeruginosa bacteremia

From: Prognostic role of time to positivity of blood culture in children with Pseudomonas aeruginosa bacteremia

Characteristics Early TTP
(TTP ≤18 h, n = 21)
Late TTP
(TTP >18 h, n = 31)
P values
Basic information
 Age(years) (median, IQR) 0.85(0.48–8.79) 2.66(0.30–9.01) 0.911
 Male (n, %) 11(52.4%) 21(67.7%) 0.384
 Weight(kilogram)(median, IQR) 8.5(7.5–24.75) 13.5(6.00–28.00) 0.668
Underlying diseases
 Hematologic malignancies (n, %) 3(14.3%) 13(41.9%) 0.070
 Congenital heart disease (n, %) 3(14.3%) 3(9.7%) 0.946
Underlying conditions
 Immunosuppression (n, %) 6(28.6%) 20(64.5%) 0.023*
 Neutropenia (n, %) 10(47.6%) 14(45.2%) 1.000
 Hypoalbuminemia (n, %) 12(57.1%) 10(32.3%) 0.093
Complications
 Pneumonia (n, %) 4(19.0%) 5(16.1%) 1.000
 Meningitis (n, %) 3(14.3%) 2(6.5%) 0.645
 Peritonitis 2(9.5%) 1(3.2%) 0.727
Origins of infection
 Respiratory tract (n, %) 11(52.4%) 11(35.5%) 0.263
 Primary bacteremia (n, %) 2(9.5%) 5(16.1%) 0.787
 Vascular-catheter related infection (n, %) 3(14.3%) 5(16.7%) 1.000
 Soft tissue infection (n, %) 2(9.5%) 6(19.4%) 0.567
 Gastrointestinal infection (n, %) 3(14.3%) 2(6.5%) 0.645
 Post-surgery or-procedure bacteremia (n, %) 0(0.0%) 2(6.5%) 0.240
Intensive unit care (n, %) 13(61.9%) 7(22.6%) 0.008*
Nosocomial infection (n, %) 7(33.3%) 15(48.4%) 0.392
Pittsburgh bacteremia scores (median, IQR) 3.00(1.00–5.00) 1.00(1.00–4.00) 0.046*
Antibiotics administration before blood culture (n, %) 12(57.1%) 19(61.3%) 0.781
Length of hospitalization days (median, IQR) 21.04(2.82–41.29) 28.92(11.92–36.71) 0.176
Multi-drug resistance bacteria (n, %) 0(0.0%) 4(12.9%) 0.090
Outcomes
 Septic shock (n, %) 11(52.4%) 4(12.9%) 0.006*
 In-hospital mortality (n, %) 9(42.9%) 3(9.7%) 0.014*
  1. * Indicates statistical significant results, P<0.05